Helena Grufman

Lund, M, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Elevated carbohydrate antigen 125 (CA125) is associated with incident heart failure and mortality in acute coronary syndrome.

Elevated carbohydrate antigen 125 (CA125) is associated with incident heart failure and mortality in acute coronary syndrome.

Journal: ESC heart failure

Published: January 23, 2024

The soluble receptor for advanced glycation end-products (sRAGE) has a dual phase-dependent association with residual cardiovascular risk after an acute coronary event.

The soluble receptor for advanced glycation end-products (sRAGE) has a dual phase-dependent association with residual cardiovascular risk after an acute coronary event.

Journal: Atherosclerosis

Published: December 28, 2018

Elevated IL-27 in patients with acute coronary syndrome is associated with adverse ventricular remodeling and increased risk of recurrent myocardial infarction and cardiovascular death.

Elevated IL-27 in patients with acute coronary syndrome is associated with adverse ventricular remodeling and increased risk of recurrent myocardial infarction and cardiovascular death.

Journal: Cytokine

Published: June 12, 2017

Sphingolipids Contribute to Human Atherosclerotic Plaque Inflammation.

Sphingolipids Contribute to Human Atherosclerotic Plaque Inflammation.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: February 15, 2015

Circulating cytokines reflect the expression of pro-inflammatory cytokines in atherosclerotic plaques.

Circulating cytokines reflect the expression of pro-inflammatory cytokines in atherosclerotic plaques.

Journal: Atherosclerosis

Published: November 27, 2014

High plasma levels of heparin-binding epidermal growth factor are associated with a more stable plaque phenotype and reduced incidence of coronary events.

High plasma levels of heparin-binding epidermal growth factor are associated with a more stable plaque phenotype and reduced incidence of coronary events.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: November 01, 2014

Increased aldehyde-modification of collagen type IV in symptomatic plaques--a possible cause of endothelial dysfunction.

Increased aldehyde-modification of collagen type IV in symptomatic plaques--a possible cause of endothelial dysfunction.

Journal: Atherosclerosis

Published: October 29, 2014

Impaired fibrous repair: a possible contributor to atherosclerotic plaque vulnerability in patients with type II diabetes.

Impaired fibrous repair: a possible contributor to atherosclerotic plaque vulnerability in patients with type II diabetes.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: July 19, 2014

Evidence for altered inflammatory and repair responses in symptomatic carotid plaques from elderly patients.

Evidence for altered inflammatory and repair responses in symptomatic carotid plaques from elderly patients.

Journal: Atherosclerosis

Published: March 23, 2014

Plasma levels of high-sensitive C-reactive protein do not correlate with inflammatory activity in carotid atherosclerotic plaques.

Plasma levels of high-sensitive C-reactive protein do not correlate with inflammatory activity in carotid atherosclerotic plaques.

Journal: Journal of internal medicine

Published: September 10, 2013

Patients with ischemic heart disease often suffers from diabetes

Patients with ischemic heart disease often suffers from diabetes

Journal: Lakartidningen

Published: July 02, 2013

Soluble urokinase plasminogen activator receptor is associated with inflammation in the vulnerable human atherosclerotic plaque.

Soluble urokinase plasminogen activator receptor is associated with inflammation in the vulnerable human atherosclerotic plaque.

Journal: Stroke

Published: November 15, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026